Terray Therapeutics

📍 Pasadena, United States🗓 Founded 2018👥 114 employees💰 Last funded Oct 2024
Biotechnology Research🌐 terraytx.com
Website LinkedIn
Terray is a biotechnology company with the technology, data, and mindset to radically change the way we discover and develop small molecule therapeutics. We explore molecules and targets broadly and deeply with a sophisticated integration of ultra-high throughput experimentation, generative AI, biology, medicinal chemistry, automation, and nanotechnology. Everything the company does is grounded in an iterative approach, producing massive amounts of precise, purpose-built data that gets increasingly valuable with each cycle of design and experimentation. The company’s platform uniquely blends experimentation and computation to improve the cost, speed, and success rate of small molecule drug discovery and development.
7
Total investors
4
Early stage
2
Mid stage
1
Late stage
2018
Founded

Investors

7 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
7
Investor activity2018–2024 · investors recorded per year
201822019120201202112023120241
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Terray Therapeutics?
Terray Therapeutics has 7 investors on record on gritt.io, including 4 early-stage backers, 2 mid-stage and 1 late-stage investors.
When did Terray Therapeutics last raise funding?
The most recent investment in Terray Therapeutics recorded on gritt.io was in October 2024.
When was Terray Therapeutics founded?
Terray Therapeutics was founded in 2018.
What industry is Terray Therapeutics in?
Terray Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Terray Therapeutics based?
Terray Therapeutics is headquartered in Pasadena, United States.